Sort
21,281 grants matching “influenza”
Investigating the development and clonal dynamics of broadly neutralizing B cells against influenza viruses
$103,503Jenna Guthmiller · University Of Chicago · K99 · FY2021 · AI
Influenza nucleoprotein interactions and viral RNA synthesis
$103,496Laura Lynn Newcomb · California State Univ San Bernardino · SC3 · FY2013 · GM
Vaccine development for Group B Neisseria meningitidis and Escherichia coli K1
$103,488Rachel Schneerson · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Novel 2'- and 3'- Branched Carbocyclic Nucleosides will be synthesized and Evalua
$103,455Vishnumurthy R Hegde · Organix, Inc. · R03 · FY2011 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$103,251Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2023 · AI
Modification of Conserved Influenza Genes Enabling their Elevated Expression
$103,180Petr O Ilyinskii · Curelab, Inc. · R43 · FY2008 · AI
RAPID: Structure of Contact Networks and the Spread of Flu-like Infectious Diseases: Implications for Dynamics and Control
$103,133James H Jones · Stanford University · · FY2009 · SBE
CAT B Existing Wyoming PRAMS
$103,123Joseph Grandpre · Wyoming State Department Of Health · U01 · FY2013 · DP
Mechanism for activation of the antiviral kinase PKR
$103,108James L Cole · University Of Connecticut Storrs · R01 · FY2010 · AI
PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED
$102,992Robert Rodriguez · University Of California, San Francisco · R01 · FY2023 · AI
Inhaled aerosols for prevention and treatment of respiratory infections
$102,851Robert W Clarke · Pulmatrix · U01 · FY2013 · AI
Improving Lyme disease diagnosis through bioinformatics
$102,720Richard B. Porwancher · Infectious Disease Consultants, Pc · R43 · FY2008 · AI
Structural and mechanistic studies for self and non-self recognition by RIG-1
$102,617Gary Alan Brewer · Rutgers, The State Univ Of N.J. · R01 · FY2016 · GM
EVALUATION OF A BOOSTER DOSE OF A/VIETNAM/1203/04 (H5N1) VACCINE ADMINISTERED
$102,605Kenneth Mathew Zangwill · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · M01 · FY2007 · RR
MICROARRAYS &MACAQUE INFLUENZA MODEL
$102,588University Of Washington · P51 · FY2005 · RR
Computational Methods for Designing Optimal Genomics-guided Viral Diagnostics
$102,577Hayden C Metsky · Broad Institute, Inc. · K01 · FY2022 · AI
Early Immune Mechanism of RSV Pathogenesis
$102,500Albert Senft · Lovelace Biomedical & Environmental Research Institute · R03 · FY2006 · AI
Policy Methods
$102,469Mark Stenius Roberts · University Of Pittsburgh At Pittsburgh · U54 · FY2018 · GM
Solid-State NMR of Viral Fusion Peptides and Proteins
$102,348David Paul Weliky · Michigan State University · R01 · FY2010 · AI
MECHANISM OF P53 DEPENDENT APOPTOSIS
$102,200Medical College Of Georgia (Mcg) · R29 · FY2000 · CA
Interactions between type I and III interferon during resolution of HCV infection
$102,087John W. Schoggins · Ut Southwestern Medical Center · K01 · FY2016 · DK
Interactions between type I and III interferon during resolution of HCV infection
$102,087John W. Schoggins · Ut Southwestern Medical Center · K01 · FY2015 · DK
Neuroimmune Mechanisms of Psychiatric Disorders
$102,050Cameron S. Carter · University Of California At Davis · P50 · FY2017 · MH
DnaK Protein Inhibitor Antimicrobials
$102,000Chaperone Technologies, Inc. · R43 · FY2003 · AI
Agent-based modeling of viral co-infection
$101,946Bert Baumgaertner · University Of Idaho · P20 · FY2015 · GM